Huadong Medicine

Focus: Huadong Medicine is a 5,000+ employee Chinese biotechnology company founded in 1993, headquartered in Hangzhou, with a focus on small molecules and traditional Chinese medicines across oncology, nephrology, neurology, and infectious diseases.

Oncology Nephrology Neurology Infectious Diseases

Profile data last refreshed 3d ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

5000+

Open Jobs

About Huadong Medicine

AI assessmentNot Hiring

No open roles listed right now. Follow Huadong Medicine to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

8 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CMGV

Recurrent Adult Acute Myeloid Leukemia

N/A

Clinical Trials (1)

NCT06329999A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

N/A

Help build intelligence for Huadong Medicine

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established 30+ year track record with 5,000+ employees provides organizational stability and career development infrastructure
Diversified pipeline spanning oncology and rare/chronic disease areas (nephrology, neurology) with multiple Phase 3 programs suggesting near-term catalysts
Unique dual expertise in Western small molecules and traditional Chinese medicine creates differentiation in Asian markets with growing global interest

Watch Out For

Zero active job openings listed signals either hiring freeze, limited international recruitment, or poor job board visibility—potential internal constraint
Pipeline data quality is mixed with many non-standard indications and clinical trial entries, suggesting possible data capture issues or unclear asset portfolio

Generated by Claude from Huadong Medicine's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

WLI Then NBI Withdrawal

Colorectal Sessile Serrated Lesion

N/A

Clinical Trials (1)

NCT05684328Narrow Band Imaging Versus White Light for the Detection and Miss of Sessile Serrated Lesion

N/A

Deep transcranial magnetic stimulation

Feeding and Eating Disorders

N/A

Clinical Trials (1)

NCT06152640A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC

N/A

Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency

Chronic Renal Insufficiency

N/A

Clinical Trials (1)

NCT02147782Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency

N/A

cold snare polypectomy

Cold Snare Resection

N/A

No intervention

Pancreatic Neoplasms

N/A

Pronase

N/A

Clinical Trials (1)

NCT06874673Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis

N/A

Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiecta

Bronchiectasis

N/A

Clinical Trials (1)

NCT04966793Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiectasis Patients.

N/A

Laryngeal mask airway（LMA）

Complications

N/A

TXI

Adenoma

N/A

Clinical Trials (1)

NCT06515977Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions

N/A

neoadjuvant immuno-chemotherapy and surgery

Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT06534489Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment

N/A

Melatonin

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT04631341Melatonin and Risk Of Cardiovascular Events And Malignant Tumors In The Elderly

N/A

Topiramate

Fluoxetine

N/A

Clinical Trials (1)

NCT04154813Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment

N/A

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging

Urothelial Carcinoma (UC)

N/A

Clinical Trials (1)

NCT07454941Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

N/A

Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right

Robotic Surgical Procedures

N/A

Clinical Trials (1)

NCT07029464Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

N/A

No intervention

Parkinsonian Disorders

N/A

Icaritin soft capsules

RFS

PHASE_2

Clinical Trials (1)

NCT07328828Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Phase 2

Gulingji capsules

Cognitive Dysfunction

PHASE_2

Clinical Trials (1)

NCT03647384Guilingji Capsule for Mild-to-moderate Cognitive Impairment

Phase 2

Yougui granules

Renal Insufficiency, Chronic

PHASE_2

Clinical Trials (1)

NCT01665651Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy